Skip To Main Content
Melissa J. Erwin on Muck Rack

Melissa J. Erwin

As seen in: Mondaq, Med-Tech Innovation
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to Melissa J. Erwin’s profile

Articles by Melissa J. Erwin

Top tips for exhibiting at international exhibitions

|
By Melissa J. Erwin
| Med-Tech Innovation Verified
Melissa Erwin, senior international officer at Medilink UK, shares what exhibitors should do to make sure they get the most out of their presence at international events. International exhibitions are a great way to showcase your medical products and services to a global audience and find out about the latest trends in the sector. However, there are some important aspects to consider before, during and after your participation, to ensure you get the highest return on your investment. 1.
Open in Who Shared Issue with article?

The New York HERO Act: Guidance For Employers

|
By Melissa J. Erwin, Jeffrey Boxer, Judith A. Lockhart
| Mondaq
To print this article, all you need is to be registered or login on Mondaq.com. On May 5, 2021, Governor Cuomo signed the New York Health and Essential Rights Act (the "HERO Act" or "Act"), which amends the New York Labor Law by adding two new sections imposing significant health and safety obligations on employers in response to the COVID-19 pandemic.
Open in Who Shared Issue with article?

Cybersecurity Starts at the Top: Risks and Concerns for Directors and Officers

|
By Matthew Dunn, Carter Ledyard, Milburn LLP, Melissa J. Erwin
| LexisNexis
Cybersecurity Starts at the Top: Risks and Concerns for Directors and Officers Posted on 03-10-2020 By: Matthew D. Dunn and Melissa J. Erwin, Carter Ledyard & Milburn LLP While many are no doubt tired of hearing about cybersecurity, hackers and cyber-criminals continue to employ sophisticated and evolving strategies to access data and disrupt organizations, and, unfortunately, this issue is not going away.
Open in Who Shared Issue with article?
Show More